This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

AdderaCare Future Growth

Future criteria checks 3/6

Key information

82.8%

Earnings growth rate

81.4%

EPS growth rate

Medical Equipment earnings growth22.0%
Revenue growth rate4.6%
Future return on equity0.9%
Analyst coverage

Low

Last updatedn/a

Recent future growth updates

Recent updates

Is Now An Opportune Moment To Examine AdderaCare AB (STO:ADDERA)?

Aug 31
Is Now An Opportune Moment To Examine AdderaCare AB (STO:ADDERA)?

We Think AdderaCare (STO:ADDERA) Can Stay On Top Of Its Debt

Jun 18
We Think AdderaCare (STO:ADDERA) Can Stay On Top Of Its Debt

Investors Could Be Concerned With AdderaCare's (STO:ADDERA) Returns On Capital

Apr 06
Investors Could Be Concerned With AdderaCare's (STO:ADDERA) Returns On Capital

AdderaCare (STO:ADDERA) Has A Pretty Healthy Balance Sheet

Jan 27
AdderaCare (STO:ADDERA) Has A Pretty Healthy Balance Sheet

AdderaCare (STO:ADDERA) Will Want To Turn Around Its Return Trends

Nov 20
AdderaCare (STO:ADDERA) Will Want To Turn Around Its Return Trends

These 4 Measures Indicate That AdderaCare (STO:ADDERA) Is Using Debt Reasonably Well

Aug 29
These 4 Measures Indicate That AdderaCare (STO:ADDERA) Is Using Debt Reasonably Well

AdderaCare (STO:ADDERA) Could Be Struggling To Allocate Capital

Aug 02
AdderaCare (STO:ADDERA) Could Be Struggling To Allocate Capital

What Does AdderaCare AB's (STO:ADDERA) Share Price Indicate?

May 24
What Does AdderaCare AB's (STO:ADDERA) Share Price Indicate?

Here's What's Concerning About AdderaCare's (STO:ADDERA) Returns On Capital

Apr 28
Here's What's Concerning About AdderaCare's (STO:ADDERA) Returns On Capital

We Think That There Are Some Issues For AdderaCare (STO:ADDERA) Beyond Its Promising Earnings

Mar 03
We Think That There Are Some Issues For AdderaCare (STO:ADDERA) Beyond Its Promising Earnings

Is There Now An Opportunity In AdderaCare AB (STO:ADDERA)?

Feb 20
Is There Now An Opportunity In AdderaCare AB (STO:ADDERA)?

We Think AdderaCare (STO:ADDERA) Has A Fair Chunk Of Debt

Jan 16
We Think AdderaCare (STO:ADDERA) Has A Fair Chunk Of Debt

Is It Time To Consider Buying AdderaCare AB (STO:ADDERA)?

Nov 22
Is It Time To Consider Buying AdderaCare AB (STO:ADDERA)?

Earnings and Revenue Growth Forecasts

OM:ADDERA - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20253082N/A231
12/31/2024307-1N/A151
12/31/2023282-1N/A141
12/31/2022259-29N/A191
9/30/2022279-27911N/A
6/30/2022283-251719N/A
3/31/202227151619N/A
12/31/202124811416N/A
9/30/202123101214N/A
6/30/20212212911N/A
3/31/2021203101415N/A
12/31/2020205101416N/A
9/30/202019851414N/A
6/30/2020199577N/A
3/31/2020208-456N/A
12/31/2019206-278N/A
9/30/2019206358N/A
6/30/201920111012N/A
3/31/2019203379N/A
12/31/201819212124N/A
9/30/2018177179N/A
6/30/201816111215N/A
3/31/2018136-12226N/A
12/31/20171284913N/A
9/30/201711651621N/A
6/30/20171054-23N/A
3/31/20171027-8-6N/A
12/31/2016946-10-9N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ADDERA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.4%).

Earnings vs Market: ADDERA is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ADDERA is expected to become profitable in the next 3 years.

Revenue vs Market: ADDERA's revenue (4.6% per year) is forecast to grow slower than the Swedish market (8.4% per year).

High Growth Revenue: ADDERA's revenue (4.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ADDERA's Return on Equity is forecast to be low in 3 years time (0.9%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.